OXFORD ASSET MANAGEMENT LLP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$477,000
-82.7%
26,913
-84.9%
0.01%
-80.3%
Q3 2019$2,758,000
-40.6%
177,789
-34.3%
0.07%
-34.0%
Q2 2019$4,646,000
+285.9%
270,458
+261.7%
0.10%
+284.6%
Q1 2019$1,204,000
+37.0%
74,784
+24.4%
0.03%
+13.0%
Q4 2018$879,000
-80.9%
60,114
-76.2%
0.02%
-76.0%
Q3 2018$4,594,000
+121.8%
253,068
+107.2%
0.10%
+140.0%
Q2 2018$2,071,000
+54.1%
122,120
+78.0%
0.04%
+42.9%
Q1 2018$1,344,000
+85.6%
68,602
+22.8%
0.03%
+55.6%
Q1 2017$724,000
-58.7%
55,863
-68.5%
0.02%
-71.0%
Q4 2016$1,752,000
-51.3%
177,311
-57.4%
0.06%
-47.5%
Q2 2016$3,594,000
-11.8%
416,512
-3.2%
0.12%
+0.9%
Q1 2016$4,077,000
+911.7%
430,476
+1764.3%
0.12%
+1070.0%
Q4 2015$403,000
-83.4%
23,091
-87.2%
0.01%
-87.0%
Q3 2015$2,429,000
-27.7%
180,890
+21.6%
0.08%
-15.4%
Q2 2015$3,358,000
-22.6%
148,698
-51.1%
0.09%
-17.3%
Q1 2015$4,340,000
+119.4%
303,939
+44.5%
0.11%
+150.0%
Q4 2014$1,978,000
-45.1%
210,403
-46.2%
0.04%
-46.3%
Q3 2014$3,601,000
+8.4%
391,073
+16.3%
0.08%
-24.1%
Q2 2014$3,322,000
-42.8%
336,235
-26.4%
0.11%
-36.1%
Q1 2014$5,804,000
+882.1%
457,047
+513.8%
0.17%
+956.2%
Q2 2013$591,00074,4610.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders